Catalog Number UNK CDS |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Embolism (1829); Endocarditis (1834); Fatigue (1849); Fever (1858); Inflammation (1932); Mitral Regurgitation (1964); Pain (1994); Sepsis (2067); Tissue Damage (2104); Diminished Pulse Pressure (2606)
|
Event Date 01/01/2013 |
Event Type
Injury
|
Manufacturer Narrative
|
Dates of event, tests, and implant: estimated dates.The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
|
Event Description
|
This is being filed to report pain, inflammation, endocarditis, tissue damage, worsening mitral regurgitation, fever, embolism, pain, sepsis, treatment with medication, and prolonged hospitalization.It was reported based on literature review, that this was a mitraclip procedure to treat mitral regurgitation (mr) with a grade of 4+.It was noted previous bioprosthetic aortic valve replacement.On an unknown date, one clip was successfully deployed, reducing mr to 1+.Approximately 14 months later, the patient returned with pain in the left calf.An echocardiogram revealed a large mass indicating endocarditis and worsening mr.The patient developed malaise and a fever with evidence of inflammation.The clip remained stable on both leaflets.The patient continued to experience pain and the large mass had disappeared but embolized into multiple smaller masses in the vicinity of the mitraclip.Although the clip was stable, the anterior leaflet seemed partially damaged.The patient was treated with antibiotics, but the patient remains in pain with endocarditis.The patient remained hospitalized and was noted to have sepsis and diminished pulse.There was no clinically significant delay in the procedure.Additional details are provided in the attached article.No additional information was provided.
|
|
Manufacturer Narrative
|
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record could not be performed as the lot information was not provided.Based on the information reviewed, a cause for reported pain in the calf, endocarditis and tissue damage.Could not be determined.The worsening mitral regurgitation resulting in fatigue, and diminished pulses appears to be cascading effects of tissue damage.Sepsis resulting in inflammation and fever, embolism appears to be cascading effects of endocarditis.The reported patient effects of endocarditis, sepsis, fever, tissue damage, worsening mitral regurgitation, embolism, pain, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.Although a conclusive cause for the reported patient effect(s), and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Event Description
|
Subsequent to the initially filed report, the following information was added: the patient had a weak left-sided pedal and popliteal pulses.No additional information was provided.
|
|
Search Alerts/Recalls
|
|